TNF Pharma receives Nasdaq bid price deficiency notice; 180 days to cure

Q/C TECHNOLOGIES, INC.

Received Nasdaq letter on March 17, 2025 for failure to maintain minimum $1.00 bid price over 30 consecutive business days.
Compliance period of 180 calendar days until September 15, 2025; must have $1.00 closing bid for 10 consecutive days.
If not cured, may get additional 180 days by meeting other listing standards and providing intent to cure, e.g., reverse stock split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.